Global Medical Aesthetics Market Size Study, by Product (Botox, Fillers, Peels, Implants, Liposuction, Microneedling, Hair Removal, Laser Resurfacing, RF, Phototherapy), Procedure (Surgical, Nonsurgical), End User (Clinics, Hospitals, Medical Spas, Beauty Centers, Home Care), and Regional Forecasts 2022-2032

February 2025 | 285 pages | ID: G9547B1F0B77EN
Bizwit Research & Consulting LLP

US$ 3,218.00 US$ 4,950.00 -35 %
Offer valid until August 31, 2025!

E-mail Delivery (PDF), Hard Copy Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Global Medical Aesthetics Market, valued at USD 15.21 billion in 2023, is poised for a robust expansion with a compound annual growth rate (CAGR) of 12.8% during the forecast period 2024-2032. This growth is underpinned by the rising preference for minimally invasive procedures, particularly among millennials and the elderly, reflecting societal shifts towards embracing aesthetic enhancements for vitality and confidence. With increasing disposable incomes in developed economies and growing consumer expenditure on health and social acceptance, the demand for medical aesthetic products and services is witnessing a significant surge.

Facial aesthetics products have secured a dominant share in the market, driven by the growing emphasis on cosmetic enhancements. The burgeoning demand for preventive treatments among younger demographics highlights an inclination towards early interventions to maintain aesthetics. Furthermore, non-surgical procedures have emerged as a preferred choice due to their minimal invasiveness, lower risk profiles, and reduced downtime, catering to a growing base of health-conscious consumers.

The Asia Pacific region is expected to register the highest growth rate, supported by enhanced healthcare infrastructure, increasing awareness about aesthetic procedures, and a thriving medical tourism industry. Additionally, the region's rising disposable incomes and expanding middle-class population further underscore its potential for market growth. North America and Europe remain significant contributors due to their advanced medical technologies and consumer awareness.

Major market players included in this report are:
  • AbbVie Inc. (US)
  • Alma Lasers (Israel)
  • Cynosure (US)
  • Johnson & Johnson (US)
  • Bausch Health Companies Inc. (Canada)
  • Cutera (US)
  • Galderma (Switzerland)
  • El.En. S.p.A. (Italy)
  • InMode Ltd (Israel)
The detailed segments and sub-segments of the market are explained below:

By Product:
  • Botox
  • Fillers
  • Peels
  • Implants
  • Liposuction
  • Microneedling
  • Hair Removal
  • Laser Resurfacing
  • RF
  • Phototherapy
By Procedure:
  • Surgical
  • Nonsurgical
By End User:
  • Clinics, Hospitals, Medical Spas
  • Beauty Centers
  • Home Care
By Region:

North America
  • U.S.
  • Canada
Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
Latin America
  • Brazil
  • Mexico
Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA
Years considered for the study are as follows:
  • Historical year: 2022
  • Base year: 2023
  • Forecast period: 2024 to 2032
Key Takeaways:
  • Comprehensive market forecasts for 10 years (2022-2032).
  • Regional and segmental revenue analysis.
  • Strategic insights into key players and market trends.
  • Recommendations for business strategies and growth.
CHAPTER 1. GLOBAL MEDICAL AESTHETICS MARKET EXECUTIVE SUMMARY

1.1. Global Medical Aesthetics Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
  1.3.1. By Product
  1.3.2. By Procedure
  1.3.3. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendations & Conclusion

CHAPTER 2. GLOBAL MEDICAL AESTHETICS MARKET DEFINITION AND RESEARCH ASSUMPTIONS

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
  2.3.1. Inclusion & Exclusion
  2.3.2. Limitations
  2.3.3. Supply-Side Analysis
    2.3.3.1. Availability
    2.3.3.2. Regulatory Environment
    2.3.3.3. Market Competition
  2.3.4. Demand-Side Analysis
    2.3.4.1. Consumer Awareness
    2.3.4.2. Technological Advancements
2.4. Estimation Methodology
2.5. Years Considered for the Study

CHAPTER 3. GLOBAL MEDICAL AESTHETICS MARKET DYNAMICS

3.1. Market Drivers
  3.1.1. Rising Popularity of Minimally Invasive Procedures
  3.1.2. Increasing Disposable Incomes
  3.1.3. Growing Geriatric Population
3.2. Market Challenges
  3.2.1. High Costs of Procedures
  3.2.2. Limited Access in Developing Regions
3.3. Market Opportunities
  3.3.1. Expansion of Medical Tourism
  3.3.2. Technological Advancements in Aesthetic Devices

CHAPTER 4. GLOBAL MEDICAL AESTHETICS MARKET INDUSTRY ANALYSIS

4.1. Porter’s Five Forces Model
  4.1.1. Bargaining Power of Suppliers
  4.1.2. Bargaining Power of Buyers
  4.1.3. Threat of New Entrants
  4.1.4. Threat of Substitutes
  4.1.5. Competitive Rivalry
4.2. PESTEL Analysis
  4.2.1. Political
  4.2.2. Economic
  4.2.3. Social
  4.2.4. Technological
  4.2.5. Environmental
  4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Analyst Recommendations & Conclusion

CHAPTER 5. GLOBAL MEDICAL AESTHETICS MARKET SIZE & FORECASTS BY PRODUCT (2022-2032)

5.1. Segment Dashboard
5.2. Botox
5.3. Fillers
5.4. Peels
5.5. Implants
5.6. Liposuction
5.7. Microneedling
5.8. Hair Removal
5.9. Laser Resurfacing
5.10. RF
5.11. Phototherapy

CHAPTER 6. GLOBAL MEDICAL AESTHETICS MARKET SIZE & FORECASTS BY PROCEDURE (2022-2032)

6.1. Segment Dashboard
6.2. Surgical
6.3. Nonsurgical

CHAPTER 7. GLOBAL MEDICAL AESTHETICS MARKET SIZE & FORECASTS BY END USER (2022-2032)

7.1. Segment Dashboard
7.2. Clinics, Hospitals, Medical Spas
7.3. Beauty Centers
7.4. Home Care

CHAPTER 8. GLOBAL MEDICAL AESTHETICS MARKET SIZE & FORECASTS BY REGION (2022-2032)

8.1. North America
  8.1.1. U.S.
  8.1.2. Canada
8.2. Europe
  8.2.1. UK
  8.2.2. Germany
  8.2.3. France
  8.2.4. Spain
  8.2.5. Italy
  8.2.6. Rest of Europe
8.3. Asia-Pacific
  8.3.1. China
  8.3.2. India
  8.3.3. Japan
  8.3.4. Australia
  8.3.5. South Korea
  8.3.6. Rest of Asia Pacific
8.4. Latin America
  8.4.1. Brazil
  8.4.2. Mexico
  8.4.3. Rest of Latin America
8.5. Middle East & Africa
  8.5.1. Saudi Arabia
  8.5.2. South Africa
  8.5.3. Rest of Middle East & Africa

CHAPTER 9. COMPETITIVE INTELLIGENCE

9.1. Key Company SWOT Analysis
  9.1.1. AbbVie Inc.
  9.1.2. Cynosure
  9.1.3. Galderma
9.2. Top Market Strategies
9.3. Company Profiles

CHAPTER 10. RESEARCH PROCESS

10.1. Research Methodology
  10.1.1. Data Collection
  10.1.2. Data Validation
  10.1.3. Data Analysis
  10.1.4. Data Triangulation
10.2. Market Estimation Techniques
  10.2.1. Top-Down Approach
  10.2.2. Bottom-Up Approach
10.3. Sources of Data
  10.3.1. Primary Research
  10.3.2. Secondary Research
  10.3.3. Expert Panel Review
10.4. Research Limitations
10.5. Assumptions & Acronyms


More Publications